Chinese General Practice · Nov 17, 2026
Predictive Value of the Olfactory Cut-off for Predicting Mild Cognitive Impairment in Patients with Type 2 Diabetes Mellitus
By Zhang Lu, Zhang Zhou, Yu Congcong et al.
Background Diabetes significantly increases the risk of cognitive impairment. Olfactory impairment is a precursor manifestation of cognitive disorders, making olfactory assessment a potential tool for identifying individuals with diabetes at high risk of cognitive impairment. However, the optimal cutoff value of olfactory tests for predicting the risk of mild cognitive impairment (MCI) in patients with type 2 diabetes mellitus (T2DM) remains unclear. Objective To investigate the predictive value and optimal cutoff of the olfactory function score for MCI development in T2DM patients. Methods This study included a cross-sectional analysis and a longitudinal cohort validation. In the cross-sectional component, we enrolled T2DM patients hospitalized in the Department of Endocrinology, The Affiliated Hospital of Nanjing University Medical School, between January 2024 and September 2025. Demographic data, laboratory parameters, cognitive function, and olfactory performance were collected (n=1 063). Participants were categorized into normal cognition and MCI groups based on established diagnostic criteria. Multivariate Logistic regression was used to assess the association between reduced olfactory function and MCI risk. Restricted cubic spline (RCS) analysis was performed to evaluate potential non-linear relationships and identify the optimal cutoff of the total olfactory score. Subgroup analyses were conducted to assess the robustness of the findings. For the longitudinal cohort, 111 T2DM patients with normal baseline cognition were followed up. Kaplan-Meier survival curves and multivariate Cox proportional hazards regression models were used to validate the predictive performance of the identified olfactory cutoff for incident MCI. Results The cross-sectional analysis included 1 063 T2DM patients (424 in the normal cognition group and 639 in the MCI group). The MCI group had significantly lower total olfactory scores than the normal cognition group [(39.9±7.2) vs (43.2±7.1), t=7.34, P<0.001]. Multivariate Logistic regression confirmed that impaired olfactory function was independently associated with higher MCI risk (OR=0.609, 95%CI=0.527-0.705, P<0.001). RCS analysis revealed a non-linear relationship between olfactory score and MCI risk (Pnon-linearity=0.045) and identified an optimal cutoff of 42 points. Patients with scores≤42 had a 114% higher risk of MCI (OR=2.14, 95%CI=1.66-2.76, P<0.05). Subgroup analyses showed consistent associations across age, sex, education level, smoking status, and comorbidities such as hypertension or dyslipidemia (all interaction P>0.05). In the longitudinal cohort, 39 of 111 participants developed MCI during a median follow-up of 9 months. Kaplan-Meier survival curve analysis showed that the low-score group (olfactory score≤42) had a significantly higher cumulative incidence of MCI than the high-score group (P=0.003), with a median time to MCI onset that was 6 months earlier. Multivariate Cox regression showed that the low-score group had a 2.61-fold higher risk of developing MCI (HR=2.61, 95%CI=1.29-5.28, P<0.05). Conclusion Impaired olfactory function is an independent risk factor for MCI in T2DM patients. Olfactory assessment has predictive value for identifying high-risk individuals, with an optimal cutoff of 42 points for the total olfactory score.